A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline

Objective To evaluate the safety profile of nicergoline compared with placebo and other active agents from published randomised controlled trials.Design Systematic review and meta-analysis of nicergoline compared with placebo and other active agents across various indications.Data sources MEDLINE, M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amit Garg, Jun Xu, Mario Fioravanti, Taku Nakashima
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2014-07-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/4/7/e005090.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adjuntive nicergoline therapy for severe persistent corneal epithelial defects.
by: Valeria Oliva-Biénzobas, et al.
Published: (2025-04-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Rituximab-associated adverse events in nephrotic syndrome: A systematic review and meta-analysis
by: Zixian Yu, et al.
Published: (2025-01-01)

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
by: Xuhui Tong, et al.
Published: (2025-01-01)

ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
by: Navneet Natt, et al.
Published: (2022-01-01)

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis
by: Shipeng Zhang, et al.
Published: (2025-01-01)

The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
by: Caroline Barkholt Kamp, et al.
Published: (2025-01-01)

Complications and adverse events of high-intensity focused ultrasound in its application to gynecological field - a systematic review and meta-analysis
by: Shan-shan Lu, et al.
Published: (2024-12-01)

Etodolac Single Dose Metabolic Profile Elucidation: Pharmacokinetics and Adverse Events in Healthy Volunteers
by: Karen Sánchez-Luquez, et al.
Published: (2025-01-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01)

Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysis
by: Suvijak Untaaveesup, et al.
Published: (2025-01-01)

Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination.
by: Shelly Melissa Pranić, et al.
Published: (2023-01-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)

Association of preoperative blood biomarkers with postoperative major adverse cardiac events and mortality in major orthopaedic surgery: a systematic review and meta-analysis
by: Lin Lu, et al.
Published: (2025-01-01)

A systematic review of machine learning applications in predicting opioid associated adverse events
by: Carlos R. Ramírez Medina, et al.
Published: (2025-01-01)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022-01-01)

Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region
by: Tian-Jun Zhao, et al.
Published: (2023-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database
by: Peiyang Cao, et al.
Published: (2025-01-01)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
by: Tingting Jiang, et al.
Published: (2025-01-01)

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xinyu Zhang, et al.
Published: (2025-01-01)

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01)

Vaginal bleeding in pregnancy and adverse clinical outcomes: a systematic review and meta-analysis
by: Arezoo Karimi, et al.
Published: (2024-12-01)

Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System
by: Shaimaa Elshafie, et al.
Published: (2025-01-01)

Data mining and analysis of adverse events of Vedolizumab based on the FAERS database
by: Qinyun Xu, et al.
Published: (2025-01-01)

Anemia during pregnancy and adverse pregnancy outcomes: a systematic review and meta-analysis of cohort studies
by: Rui Wang, et al.
Published: (2025-01-01)

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database
by: Yalan Tian, et al.
Published: (2025-01-01)

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Wenchao Lu, et al.
Published: (2025-01-01)

Adverse childhood experiences and elder abuse victimization nexus: A systematic review and meta-analysis.
by: Kofi Awuviry-Newton, et al.
Published: (2025-01-01)

Scanning and vicarious learning from adverse events in health care
Published: (2001-01-01)

Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
by: D. Valančius, et al.
Published: (2021-12-01)

Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
by: Gian Lima, et al.
Published: (2019-01-01)

Examining vaccination-related adverse events in frequent neurodegenerative diseases
by: Shabnam Sodagari, et al.
Published: (2025-02-01)

Rates of Minor Adverse Events and Health Resource Utilization Postcolonoscopy
by: Vladimir Marquez Azalgara, et al.
Published: (2014-01-01)

Association between frailty and hospital-related adverse events in older hospitalised patients: a systematic literature review protocol
by: Jay Banerjee, et al.
Published: (2025-02-01)

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database
by: Qun Li, et al.
Published: (2025-02-01)

Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese adverse drug event report database: a retrospective pharmacovigilance study
by: Yusuke Kan, et al.
Published: (2025-01-01)